Stueland Katherine — SEC Form 4 filings
SEC reporting owner CIK 1689575. 43 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 43 filings on record, filed 2024-03-12 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 114 legs across 41 filings — 484,860 shares, $39,116,954 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 73.
- Largest priced transaction: sale of 44,801 shares @ $95.66 ($4,285,561) in GeneDx Holdings Corp., filed 2025-03-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER, Director | 43 | — | 114 legs · 484,860 sh · $39,116,954 | 73 |
Form 4 filings — Stueland Katherine
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 18,750 @ $0 · Sale (S): 1,648 @ $94.26 · Sale (S): 148 @ $95.41 · Sale (S): 1,525 @ $96.90 · Sale (S): 4,141 @ $98.27 · Sale (S): 3,039 @ $99.00 · +1 more | EDGAR |
| 2026-09-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,547 @ $0 · Sale (S): 3,692 @ $84.22 · Option exercise (M): 6,547 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 18,750 @ $0 · Sale (S): 2,140 @ $59.75 · Sale (S): 5,932 @ $60.83 · Sale (S): 2,429 @ $61.50 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,546 @ $0 · Sale (S): 3,639 @ $53.77 · Option exercise (M): 6,546 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,874 @ $0 · Sale (S): 2,154 @ $65.20 · Sale (S): 18 @ $64.12 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 80,000 @ $0 · Sale (S): 13,229 @ $61.29 · Sale (S): 5,117 @ $62.33 · Sale (S): 13,412 @ $63.28 · Sale (S): 5,292 @ $64.60 · Sale (S): 9,883 @ $65.21 · +1 more | EDGAR |
| 2026-03-17 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 11,921 @ $0 · Option exercise (M): 18,750 @ $0 · Sale (S): 7,178 @ $76.35 · Sale (S): 9,229 @ $77.05 · Sale (S): 772 @ $77.94 · Option exercise (M): 11,921 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,546 @ $0 · Sale (S): 3,678 @ $86.75 · Option exercise (M): 6,546 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | GeneDx Holdings Corp. (WGS) | Grant/award (A): 3,404 @ $88.11 | EDGAR |
| 2026-03-05 | 4 | GeneDx Holdings Corp. (WGS) | Grant/award (A): 47,684 @ $0 · Sale (S): 5,861 @ $77.63 · Sale (S): 10,465 @ $78.61 · Sale (S): 9,133 @ $79.25 · Grant/award (A): 40,418 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,874 @ $0 · Sale (S): 1,653 @ $94.00 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 18,750 @ $0 · Sale (S): 369 @ $138.93 · Sale (S): 1,031 @ $140.08 · Sale (S): 2,679 @ $141.20 · Sale (S): 604 @ $142.12 · Sale (S): 940 @ $144.27 · +7 more | EDGAR |
| 2025-12-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,547 @ $0 · Sale (S): 3,639 @ $159.28 · Option exercise (M): 6,547 (derivative) @ $0 | EDGAR |
| 2025-10-31 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,874 @ $0 · Sale (S): 2,154 @ $136.54 · Sale (S): 4 @ $136.75 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 606 @ $105.10 · Sale (S): 1,092 @ $106.69 · Sale (S): 4,462 @ $107.61 · Sale (S): 5,163 @ $108.55 · Sale (S): 554 @ $109.13 · Sale (S): 200 @ $110.23 · +2 more | EDGAR |
| 2025-09-18 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 18,750 @ $0 · Sale (S): 10,501 @ $121.47 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,546 @ $0 · Sale (S): 3,639 @ $128.05 · Sale (S): 18 @ $129.08 · Option exercise (M): 6,546 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,874 @ $0 · Sale (S): 2,154 @ $105.31 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-07-11 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 3,220 @ $93 | EDGAR |
| 2025-07-03 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 6,928 @ $90.68 · Sale (S): 2,594 @ $91.55 · Sale (S): 135 @ $92.46 | EDGAR |
| 2025-06-18 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 18,750 @ $0 · Sale (S): 10,501 @ $64.77 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,547 @ $0 · Sale (S): 3,639 @ $72.55 · Option exercise (M): 6,547 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,874 @ $0 · Sale (S): 2,154 @ $113.09 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-04-10 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 2,024 @ $81.16 · Sale (S): 3,134 @ $82.17 · Sale (S): 3,297 @ $83.25 · Sale (S): 2,745 @ $84.28 · Sale (S): 3,175 @ $85.44 · Sale (S): 5,855 @ $86.34 · +10 more | EDGAR |
| 2025-03-28 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 80,000 @ $0 · Sale (S): 44,801 @ $95.66 · Sale (S): 1,750 @ $94.58 · Option exercise (M): 80,000 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 1,078 @ $89.44 · Option exercise (M): 18,750 @ $0 · Sale (S): 10,559 @ $96.71 · Grant/award (A): 320,000 (derivative) @ $0 · Grant/award (A): 47,684 (derivative) @ $0 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,546 @ $0 · Sale (S): 2,731 @ $94.73 · Option exercise (M): 6,546 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,874 @ $0 · Sale (S): 1,657 @ $78.48 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 23,800 @ $93.34 · Sale (S): 8,439 @ $94.33 · Sale (S): 9,176 @ $95.50 · Sale (S): 10,005 @ $96.39 | EDGAR |
| 2025-01-06 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 2,654 @ $75.47 · Sale (S): 2,051 @ $76.54 · Sale (S): 3,417 @ $77.88 · Sale (S): 4,078 @ $78.58 · Sale (S): 4,242 @ $79.68 · Sale (S): 1,564 @ $80.47 | EDGAR |
| 2024-12-18 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 18,750 @ $0 · Sale (S): 10,501 @ $76.75 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,547 @ $0 · Sale (S): 3,661 @ $76.37 · Option exercise (M): 6,547 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 5,497 @ $68.65 · Sale (S): 4,800 @ $69.67 · Sale (S): 7,240 @ $70.72 · Sale (S): 1,958 @ $71.49 · Sale (S): 2,043 @ $72.95 · Sale (S): 1,510 @ $73.71 · +7 more | EDGAR |
| 2024-10-31 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,874 @ $0 · Sale (S): 2,154 @ $66.60 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 18,750 @ $0 · Sale (S): 10,501 @ $37.59 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2024-09-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,546 @ $0 · Sale (S): 3,639 @ $33.33 · Option exercise (M): 6,546 (derivative) @ $0 | EDGAR |
| 2024-07-31 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,874 @ $0 · Sale (S): 2,154 @ $33.54 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 18,750 @ $0 · Sale (S): 7,683 @ $28.31 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,546 @ $0 · Sale (S): 2,652 @ $24.92 · Option exercise (M): 6,546 (derivative) @ $0 | EDGAR |
| 2024-04-30 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 15,496 @ $0 · Sale (S): 6,325 @ $11.04 · Option exercise (M): 15,496 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 18,750 @ $0 · Sale (S): 8,559 @ $10.59 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2024-03-13 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 2,618 @ $9.21 | EDGAR |
| 2024-03-12 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 6,547 @ $0 · Option exercise (M): 6,547 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1689575 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →